Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
A 12-week randomized controlled trial of twice-daily intranasal oxytocin for social cognitive deficits in people with schizophrenia.
Journal: Schizophrenia research
Published: July 16, 2016
A naturalistic comparison of the long-term metabolic adverse effects of clozapine versus other antipsychotics for patients with psychotic illnesses.
Journal: Journal of clinical psychopharmacology
Published: June 20, 2014
Intranasal oxytocin blocks alcohol withdrawal in human subjects.
Journal: Alcoholism, clinical and experimental research
Published: May 06, 2012
Showing 1-3 of 3
Last Updated: 09/26/2026